Subscribe to RSS
DOI: 10.1055/s-0043-1766107
Minimized Hemodiafiltration for Extracorporeal Membrane Oxygenation in Infants
Abstract
Background Fluid overload is a serious complication in the treatment of infants with extracorporeal membrane oxygenation (ECMO). Volume overload leads to prolonged ECMO therapy if left untreated. The renal replacement therapy of choice in pediatric patients is peritoneal dialysis or conventional dialysis using a “large” hemofiltration machine via a Shaldon catheter or directly connected to the ECMO system. This study describes the implementation of a novel minimized hemodiafiltration (HDF) system in pediatric patients on ECMO.
Methods This retrospective analysis included 13 infants up to 5 kg who underwent 15 veno-arterial (V-A) ECMO runs with HDF. A minimized HDF system is integrated into an existing ECMO system (18 mL priming volume), connected post-oxygenation to the venous line, before the ECMO pump. Two infusion pumps are attached to the inlet and outlet of the hemofilter to control the HDF system.
In addition to retention values (creatine and urea) at six defined time points, flow rates, dialysis parameters, and volume withdrawal were examined, as well as the number of HDF system changes.
Results With a mean ECMO runtime of 156 hours, the HDF system was utilized for 131 hours. The mean blood flow through the hemofilter was 192 mL/min. The mean dialysate flow was 170 mL/h, with a mean volume deprivation of 39 mL/h. The HDF system was changed once in seven cases and twice in three cases.
Conclusion There were no complications with the minimized HDF system in all 15 applications. It allows safe patient volume management when treating infants with ECMO, with effective elimination of urinary substances.
Keywords
hemodiafiltration - infants - creatinine clearance - ECMO - hemofiltration - urea - phosphatePublication History
Received: 30 May 2022
Accepted: 29 December 2022
Article published online:
10 April 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Perry T, Brown T, Misfeldt A, Lehenbauer D, Cooper DS. Extracorporeal membrane oxygenation in congenital heart disease. Children (Basel) 2022; 9 (03) 380
- 2 Teske A, Rieben H, Heinicke T. Eine variante von NEV an ECMO. Intensiv 2020; 28 (04) 178-182
- 3 Münch F, Purbojo A, Cesnjevar R, Teske A. Update hämofiltration und hämoperfusion. KARDIOTECHNIK 2019; 2: 11
- 4 Gorga SM, Sahay RD, Askenazi DJ. et al. Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy: a multicenter retrospective cohort study. Pediatr Nephrol 2020; 35 (05) 871-882
- 5 Gorga SM, Lima L, Askenazi DJ. et al. Fluid balance management informs renal replacement therapy use during pediatric extracorporeal membrane oxygenation: a survey report from the kidney intervention during extracorporeal membrane oxygenation group. ASAIO J 2022; 68 (03) 407-412
- 6 Ronco C, Garzotto F, Brendolan A. et al. Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM). Lancet 2014; 383 (9931): 1807-1813